Results 71 to 80 of about 32,649 (166)

Beyond the chimeric antigen receptor T cells and bispecific antibody duopoly: ex vivo armed T cells for solid tumors. [PDF]

Front Immunol
Park JA, Cheung NV.
europepmc   +1 more source

Epstein-Barr virus-associated multiple sclerosis: recent mechanistic advances and clinical therapeutic perspectives. [PDF]

Front Immunol
Cheng R, Gao Y, Zheng R, Wen M, Li G, Pan W, Liao Y, Wen L, Hu Y, Zhao-Fleming H, Shang P.   +10 more
europepmc   +1 more source

The B-cell-autoantibody axis in lung cancer immunity. [PDF]

Theranostics
Huang Y, Hu H, Sun R, Wang Y.
europepmc   +1 more source

Case Report: Compromised response of memory-formed bystander T cells after CD19 CAR-T cell therapy following CD20 bispecific antibody therapy. [PDF]

Front Immunol
Masuda Y, Kato J, Konishi T, Honda T, Maruta M, Kawasaki N, Matsumoto M, Oka K, Mori K, Nabe S, Miyazaki Y, Matsubara E, Urata S, Kinnami S, Doi Y, Takasuka Y, Yamanouchi J, Ochi T, Takenaka K.   +18 more
europepmc   +1 more source

Humoral and Cellular Immune Response in Patients with Hematological Disorders After Three Doses of mRNA COVID-19 Vaccine: A Single-Center Observational Study. [PDF]

Vaccines (Basel)
Daffini R, Zecchini F, Venneri G, Malagola M, Cattaneo C, Calza S, Caruso A, Tucci A, Giagulli C.   +8 more
europepmc   +1 more source

Exploring current evidence on bispecific CAR-T cell therapy for acute leukemias: a systematic review. [PDF]

Front Oncol
Husodho GVP, Kumalasari ADA, Faiza AH, Limijadi EKS, Hendrianingtyas M.   +4 more
europepmc   +1 more source

Integrating Flow Cytometry in the Diagnostic Work of HIV-Associated Hodgkin's Lymphomas. [PDF]

J Cell Mol Med
Santa M, Cenariu D, Tigu AB, Damian M, Rantshabeng P, Gaolathe T, Ndlovu AK, Abdelrahman K, Nistor M, Kegyes D, Gulei D, Jinca C, Bancos A, Rus I, Bumbea H, Tomacinschii V, Buruiana S, Bilal R, Selicean C, Zdrenghea M, Fetica B, Stefan C, Fromm J, Tomuleasa C.   +23 more
europepmc   +1 more source

Experimental Therapies in Multiple Sclerosis: Epstein-Barr Virus and Potential EBV-Related Therapeutic Strategies-A Systematic Review. [PDF]

J Clin Med
Bartczak J, Gronowski P, Małek M, Denkiewicz A, Grodzka O, Chądzyński P, Domitrz I.   +6 more
europepmc   +1 more source

Advances in Nanotechnology for Lymphoma Treatment: Targeted Delivery, Immunomodulation, and TME-Responsive Therapy Strategies. [PDF]

Int J Nanomedicine
Han B, Han Z, Zhang Y.
europepmc   +1 more source

Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease. [PDF]

Research (Wash D C)
Shao W, Liu J, Sun M, Yu D.
europepmc   +1 more source